scholarly journals Changes in Red Blood Cell Behavior during Cerebral Blood Flow Increase in the Rat Somatosensory Cortex: A Study of Laser-Doppler Flowmetry.

2001 ◽  
Vol 51 (6) ◽  
pp. 703-708 ◽  
Author(s):  
Tetsuya Matsuura ◽  
Iwao Kanno
Keyword(s):  
Blood Flow ◽  
Cerebral Blood Flow ◽  
Blood Cell ◽  
Somatosensory Cortex ◽  
Laser Doppler Flowmetry ◽  
Red Blood Cell ◽  
Cell Behavior ◽  
Doppler Flowmetry ◽  
Blood Flow Increase ◽  
Rat Somatosensory Cortex

scholarly journals The Angiotensin II Type 1—Receptor Blocker Candesartan Increases Cerebral Blood Flow, Reduces Infarct Size, and Improves Neurologic Outcome after Transient Cerebral Ischemia in Rats

2004 ◽  
Vol 24 (4) ◽  
pp. 467-474 ◽  
Author(s):  
Tobias Engelhorn ◽  
Sophia Goerike ◽  
Arnd Doerfler ◽  
Christine Okorn ◽  
Michael Forsting ◽  
...  
Keyword(s):  
Blood Flow ◽  
Cerebral Blood Flow ◽  
Angiotensin Ii ◽  
Cerebral Ischemia ◽  
Infarct Size ◽  
Laser Doppler Flowmetry ◽  
Transient Cerebral Ischemia ◽  
Doppler Flowmetry ◽  
Treatment Regimens

The goal of the present study was to test the impact of administration time of the angiotensin II type 1–receptor blocker candesartan on cerebral blood flow (CBF), infarct size, and neuroscore in transient cerebral ischemia. Therefore, 1-hour middle cerebral artery occlusion (MCAO) was followed by reperfusion. Rats received 0.5-mg/kg candesartan intravenously 2 hours before MCAO (pretreatment), 24 hours after MCAO, every 24 hours after MCAO, or 2 hours before and every 24 hours after MCAO. Infarct size (mm3) and a neuroscore at day 7 were compared with controls. CBF was quantified by radiolabeled microspheres and laser-Doppler flowmetry. Compared with controls (95 ± 8), infarct size in candesartan-treated groups was smaller (59 ± 5, 68 ± 10, 28 ± 3, and 15 ± 3, respectively; P < 0.05). Although there was no difference in neuroscore between pretreatment and controls (1.55 ± 0.18, 1.80 ± 0.13), other treatment regimens resulted in improved neuroscores (1.33 ± 0.16, 1.11 ± 0.11, 0.73 ± 0.15; P < 0.05). CBF in pretreated animals at 0.5 hours after MCAO was significantly higher than in controls (0.58 ± 0.09 mL · g−1 ·· min−1 and 44% ± 7% of baseline compared with 0.49 ± 0.06 mL · g−1 ·· min−1 and 37% ± 6%, microspheres and laser-Doppler flowmetry; P < 0.05). Thus, candesartan reduces infarct size even if administered only during reperfusion. Apart from pretreatment, other treatment regimens result in significantly improved neuroscores. In the acute phase of cerebral ischemia, candesartan increases CBF.

scholarly journals Endothelial Nitric Oxide Synthase-Dependent Cerebral Blood Flow Augmentation by L-Arginine After Chronic Statin Treatment

2000 ◽  
Vol 20 (4) ◽  
pp. 709-717 ◽  
Author(s):  
Masaru Yamada ◽  
Zhihong Huang ◽  
Turgay Dalkara ◽  
Matthias Endres ◽  
Ulrich Laufs ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Blood Flow ◽  
Cerebral Blood Flow ◽  
Nitric Oxide Synthase ◽  
Laser Doppler Flowmetry ◽  
Brain Blood Flow ◽  
Arginine Infusion ◽  
Doppler Flowmetry ◽  
Ischemic Brain ◽  
Oxide Synthase

Nitric oxide, a product of nitric oxide synthase activity, relaxes vascular smooth muscle and elevates brain blood flow. We evaluated the importance of eNOS to cerebral blood flow augmentation after L-arginine infusion and increases in flow after eNOS upregulation in SV-129 mice. Blood flow was measured by laser-Doppler flowmetry before and after L-arginine infusion (450 mg/kg during a 15-minute period) or measured by 14C-iodoamphetamine indicator fractionation or 14C-iodoantipyrine tissue equilibration techniques. rCBF increased by 26% (laser Doppler flowmetry) after L-arginine infusion but did not change in mutant mice deficient in eNOS expression. After eNOS upregulation by chronic simvastatin treatment (2 mg/kg subcutaneously, daily for 14 days), L-arginine amplified and sustained the hyperemia (38%) and increased absolute brain blood flow from 86 ± 7 to 119 ± 10 mL/100 g per minute. Furthermore, pretreatment with simvastatin enhanced blood flow within ischemic brain tissue after middle cerebral artery occlusion. Together, these findings suggest that eNOS activity is critical for blood flow augmentation during acute L-arginine infusion, and chronic eNOS upregulation combined with L-arginine administration provides a novel strategy to elevate cerebral blood flow in the normal and ischemic brain.

The Characteristics of Laser-Doppler Flowmetry for the Measurement of Regional Cerebral Blood Flow

Neurosurgery ◽  
1995 ◽  
Vol 36 (2) ◽  
pp. 358???364 ◽  
Author(s):  
Osamu Fukuda ◽  
Shunro Endo ◽  
Naoya Kuwayama ◽  
Jun Harada ◽  
Akira Takaku
Keyword(s):  
Blood Flow ◽  
Cerebral Blood Flow ◽  
Laser Doppler Flowmetry ◽  
Regional Cerebral Blood Flow ◽  
Laser Doppler ◽  
Regional Cerebral Blood ◽  
Doppler Flowmetry

Effect of nimodipine on the autoregulation of cerebral blood flow studied by laser-Doppler flowmetry

1993 ◽  
Vol 625 (2) ◽  
pp. 301-306 ◽  
Author(s):  
Geneviève Florence ◽  
Gilles Bonvento ◽  
Pascal Roucher ◽  
Robert Charbonne ◽  
Jacques Seylaz
Keyword(s):  
Blood Flow ◽  
Cerebral Blood Flow ◽  
Laser Doppler Flowmetry ◽  
Laser Doppler ◽  
Doppler Flowmetry
Sign in / Sign up

Export Citation Format

Share Document